[1]
Faltraco, F.; Palm, D.; Coogan, A.; Simon, F.; Tucha, O.; Thome, J. Molecular link between circadian rhythmicity and mood disorders. Curr. Med. Chem., 2022, 29, 5692-5709.
[2]
Vecchia, A.D.; Arone, A.; Piccinni, A.; Mucci, F.; Marazziti, D. GABA system in depression: Impact on pathophysiology and psychopharmacology. Curr. Med. Chem., 2022, 29, 5710-5730.
[3]
Pagni, G.; Tagliarini, C.; Carbone, M.G.; Imbimbo, B.P.; Marazziti, D.; Pomara, N. Different sides of depression in the elderly: an in-depth view on the role of Aβ peptides. Curr. Med. Chem., 2022, 29, 5731-5757.
[4]
Marazziti, D.; Torrigiani, S.; Carbone, M.G.; Mucci, F.; Flamini, W.; Ivaldi, T.; Dell’Osso, L. Neutrophil/lymphocyte, platelet/lymphocyte, and monocyte/lymphocyte ratios in mood disorders. Curr. Med. Chem., 2022, 29, 5758-5781.
[5]
D’Addario, C.; Macellaro, M.; Bellia, F.; Benatti, B.; Annunzi, E.; Palumbo, R.; Conti, D.; Fasciana, F.; Vismara, M.; Varinelli, A.; Ferrara, L.; Celebre, L.; Viganò, C.; Dell’Osso, B. In search for biomarkers in obsessive-compulsive disorder: new evidence on saliva as a practical source of DNA to assess epigenetic regulation. Curr. Med. Chem., 2022, 29, 5782-5791.
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Article Metrics
12
1